相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PIK3CA gene alterations in bladder cancer are frequent and associate with reduced recurrence in non-muscle invasive tumors
Marta Duenas et al.
MOLECULAR CARCINOGENESIS (2015)
Akt Signaling Leads to Stem Cell Activation and Promotes Tumor Development in Epidermis
Carmen Segrelles et al.
STEM CELLS (2014)
Selective Requirement of PI3K/PDK1 Signaling for Kras Oncogene-Driven Pancreatic Cell Plasticity and Cancer
Stefan Eser et al.
CANCER CELL (2013)
Genetically engineered mouse models of PI3K signaling in breast cancer
Sjoerd Klarenbeek et al.
MOLECULAR ONCOLOGY (2013)
Conditional activation of Pik3caH1047R in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutations
W. Yuan et al.
ONCOGENE (2013)
Conditional Transgenic Expression of PIM1 Kinase in Prostate Induces Inflammation-Dependent Neoplasia
Maja Narlik-Grassow et al.
PLOS ONE (2013)
Expression of PIK3CA mutant E545K in the mammary gland induces heterogeneous tumors but is less potent than mutant H1047R
D. S. Meyer et al.
ONCOGENESIS (2013)
Recent Progress in Mouse Models for Tumor Suppressor Genes and its Implications in Human Cancer
Kazushi Inoue et al.
CLINICAL MEDICINE INSIGHTS-ONCOLOGY (2013)
PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab
J. D. Jensen et al.
ANNALS OF ONCOLOGY (2012)
Mutational characterization of individual breast tumors: TP53 and PI3K pathway genes are frequently and distinctively mutated in different subtypes
Sandrine Boyault et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
The essential role of PIM kinases in sarcoma growth and bone invasion
Maja Narlik-Grassow et al.
CARCINOGENESIS (2012)
Telomerase Reactivation following Telomere Dysfunction Yields Murine Prostate Tumors with Bone Metastases
Zhihu Ding et al.
CELL (2012)
Nkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis
Philip D. Anderson et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Physiological Levels of Pik3caH1047R Mutation in the Mouse Mammary Gland Results in Ductal Hyperplasia and Formation of ERα-Positive Tumors
Anjali Tikoo et al.
PLOS ONE (2012)
EMT and induction of miR-21 mediate metastasis development in Trp53-deficient tumours
Olga Bornachea et al.
SCIENTIFIC REPORTS (2012)
A Novel Tumor suppressor network in squamous malignancies
Clotilde Costa et al.
SCIENTIFIC REPORTS (2012)
Cell Autonomous Role of PTEN in Regulating Castration-Resistant Prostate Cancer Growth
David J. Mulholland et al.
CANCER CELL (2011)
Cooperation between Pik3ca and p53 Mutations in Mouse Mammary Tumor Formation
Jessica R. Adams et al.
CANCER RESEARCH (2011)
Luminal Expression of PIK3CA Mutant H1047R in the Mammary Gland Induces Heterogeneous Tumors
Dominique S. Meyer et al.
CANCER RESEARCH (2011)
Activation of the PIK3CA/AKT Pathway Suppresses Senescence Induced by an Activated RAS Oncogene to Promote Tumorigenesis
Alyssa L. Kennedy et al.
MOLECULAR CELL (2011)
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
Zhihu Ding et al.
NATURE (2011)
Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanisms
Pixu Liu et al.
NATURE MEDICINE (2011)
Hot-spot mutations in p110α of phosphatidylinositol 3-kinase (PI3K) Differential interactions with the regulatory subunit p85 and with RAS
Li Zhao et al.
CELL CYCLE (2010)
The PKB/AKT Pathway in Cancer
Amancio Carnero
CURRENT PHARMACEUTICAL DESIGN (2010)
PIK3CA mutations mostly begin to develop in ductal carcinoma of the breast
Hua Li et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2010)
PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality
Elena Lopez-Knowles et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Exploring the Gain of Function Contribution of AKT to Mammary Tumorigenesis in Mouse Models
Carmen Blanco-Aparicio et al.
PLOS ONE (2010)
Akt Activation Synergizes with Trp53 Loss in Oral Epithelium to Produce a Novel Mouse Model for Head and Neck Squamous Cell Carcinoma
Marta Moral et al.
CANCER RESEARCH (2009)
Mouse Models to Decipher the PI3K Signaling Network in Human Cancer
Oliver Renner et al.
CURRENT MOLECULAR MEDICINE (2009)
PTEN Deficiency in a Luminal ErbB-2 Mouse Model Results in Dramatic Acceleration of Mammary Tumorigenesis and Metastasis
Babette Schade et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Interactions between Cells with Distinct Mutations in c-MYC and Pten in Prostate Cancer
Jongchan Kim et al.
PLOS GENETICS (2009)
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Jeffrey A. Engelman
NATURE REVIEWS CANCER (2009)
A prostatic intraepithelial neoplasia-dependent p27Kip1 checkpoint induces senescence and inhibits cell proliferation and cancer progression
Pradip K. Majumder et al.
CANCER CELL (2008)
Activation of Phosphatidylinositol 3-Kinase by Membrane Localization of p110α Predisposes Mammary Glands to Neoplastic Transformation
Oliver Renner et al.
CANCER RESEARCH (2008)
Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mouse model of lung cancer
Kentaro Iwanaga et al.
CANCER RESEARCH (2008)
Spontaneous squamous cell carcinoma induced by the somatic inactivation of retinoblastoma and Trp53 tumor suppressors
Belen Ana Martínez-Cruz et al.
CANCER RESEARCH (2008)
Integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer
Katherine Stemke-Hale et al.
CANCER RESEARCH (2008)
Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice
Takiko Daikoku et al.
CANCER RESEARCH (2008)
Pten haploinsufficiency accelerates formation of high-grade astrocytomas
Chang-Hyuk Kwon et al.
CANCER RESEARCH (2008)
Genetic modelling of the PTEN/AKT pathway in cancer research
Oliver Renner et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2008)
The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications
Amancio Carnero et al.
CURRENT CANCER DRUG TARGETS (2008)
Angiogenesis selectively requires the p110α isoform of PI3K to control endothelial cell migration
Mariona Graupera et al.
NATURE (2008)
Essential roles of PI(3)K-p110β in cell growth, metabolism and tumorigenesis
Shidong Jia et al.
NATURE (2008)
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
Jeffrey A. Engelman et al.
NATURE MEDICINE (2008)
The PTEN-PI3K pathway: of feedbacks and cross-talks
A. Carracedo et al.
ONCOGENE (2008)
Class IPI3K in oncogenic cellular transformation
L. Zhao et al.
ONCOGENE (2008)
PI3K pathway alterations in cancer: variations on a theme
T. L. Yuan et al.
ONCOGENE (2008)
Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair
Lao H. Saal et al.
NATURE GENETICS (2008)
Deregulated activity of akt in epithelial basal cells induces spontaneous tumors and heightened sensitivity to skin carcinogenesis
Carmen Segrelles et al.
CANCER RESEARCH (2007)
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer
Katrien Berns et al.
CANCER CELL (2007)
A transforming mutation in the pleckstrin homology domain of AKT1 in cancer
John D. Carpten et al.
NATURE (2007)
Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate
Oliver Renner et al.
CARCINOGENESIS (2007)
AKT/PKB signaling: Navigating downstream
Brendan D. Manning et al.
CELL (2007)
The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas
Eva Hernando et al.
NATURE MEDICINE (2007)
Binding of Ras to phosphoinositide 3-kinase p110α is required for Ras-driven tumorigenesis in mice
Surbhi Gupta et al.
CELL (2007)
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity
Lao H. Saal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Akt1 governs breast cancer progression in vivo
Xiaoming Ju et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Physiological roles of PKB/Akt isoforms in development and disease
B. Dummler et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines
Antoinette Hollestelle et al.
MOLECULAR CANCER RESEARCH (2007)
Localization of agonist-sensitive PtdIns(3,4,5)P3 reveals a nuclear pool that is insensitive to PTEN expression
Yvonne Lindsay et al.
JOURNAL OF CELL SCIENCE (2006)
Life with a single isoform of Akt: Mice lacking Akt2 and Akt3 are viable but display impaired glucose homeostasis and growth deficiencies
Bettina Dummler et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Mouse Modeling in oncologic preclinical and translational research
Brett S. Carver et al.
CLINICAL CANCER RESEARCH (2006)
PCAF modulates PTEN activity
Koichi Okumura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Mechanistic insights into maintenance of high p53 acetylation by PTEN
Andrew G. Li et al.
MOLECULAR CELL (2006)
Emergence of androgen independence at early stages of prostate cancer progression in Nkx3.1;: Pten mice
Hui Gao et al.
CANCER RESEARCH (2006)
Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms
Kentaro Nakayama et al.
CANCER BIOLOGY & THERAPY (2006)
Genetic background controls tumor development in Pten-deficient mice
Dan Freeman et al.
CANCER RESEARCH (2006)
Molecular determinants of Akt-induced keratinocyte transformation
C Segrelles et al.
ONCOGENE (2006)
PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways
DG Yao et al.
CANCER RESEARCH (2006)
Cancer-specific mutations in PIK3CA are oncogenic in vivo
AG Bader et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The oncogenic properties of mutant p110α and p110β phosphatidylinositol 3-kinases in human mammary epithelial cells
JJ Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Mutation of the PIK3CA gene in anaplastic thyroid cancer
G García-Rostán et al.
CANCER RESEARCH (2005)
Class reunion: PTEN joins the nuclear crew
ZL Lian et al.
ONCOGENE (2005)
Akt-dependent transformation: there is more to growth than just surviving
DR Plas et al.
ONCOGENE (2005)
Hypomorphic mutation of PDK1 suppresses tumorigenesis in PTEN+/- mice
JR Bayascas et al.
CURRENT BIOLOGY (2005)
AKT activation predicts outcome in breast cancer patients treated with tamoxifen
T Kirkegaard et al.
JOURNAL OF PATHOLOGY (2005)
Pten constrains centroacinar cell expansion and malignant transformation in the pancreas
BZ Stanger et al.
CANCER CELL (2005)
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
ZB Chen et al.
NATURE (2005)
Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits Wnt-1-induced mammary tumorigenesis
H Zhao et al.
CANCER RESEARCH (2005)
Membrane localization of all class IPI 3-kinase isoforms suppresses c-Myc-induced apoptosis in Rat1 fibroblasts via Akt
W Link et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
Somatic induction of Pten loss in a preclinical astrocytoma model reveals major roles in disease progression and avenues for target discovery and validation
A Xiao et al.
CANCER RESEARCH (2005)
A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumor resistance
DY Xing et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma
LH Saal et al.
CANCER RESEARCH (2005)
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic
SY Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Activation of Akt-1 (PKB-α) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion
JN Hutchinson et al.
CANCER RESEARCH (2004)
High frequency of mutations of the PIK3CA gene in human cancers
Y Samuels et al.
SCIENCE (2004)
PI 3-kinase, Akt and cell survival
J Downward
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2004)
Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas
DK Broderick et al.
CANCER RESEARCH (2004)
The PIK3CA gene is mutated with high frequency in human breast cancers
KE Bachman et al.
CANCER BIOLOGY & THERAPY (2004)
PTEN regulates Mdm2 expression through the P1 promoter
CJ Chang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-κB and c-Myc in pancreatic cancer cells
T Asano et al.
ONCOGENE (2004)
Mutation of the PIK3CA gene in ovarian and breast cancer
IG Campbell et al.
CANCER RESEARCH (2004)
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
SY Wang et al.
CANCER CELL (2003)
PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1
A Radu et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: The MPAKT model
PK Majumder et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms
DJ Freeman et al.
CANCER CELL (2003)
Targeting ras signalling pathways in cancer therapy
J Downward
NATURE REVIEWS CANCER (2003)
Regulation of p53: intricate loops and delicate balances
M Oren et al.
BIOCHEMICAL PHARMACOLOGY (2002)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Delayed mammary gland involution in MMTV-AKT1 transgenic mice
S Ackler et al.
ONCOGENE (2002)
Functional roles of Akt signaling in mouse skin tumorigenesis
C Segrelles et al.
ONCOGENE (2002)
Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation
A Xiao et al.
CANCER CELL (2002)
Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease
SA Backman et al.
NATURE GENETICS (2001)
Knockout mouse models and mammary tumorigenesis
CX Deng et al.
SEMINARS IN CANCER BIOLOGY (2001)
A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus
LD Mayo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Regulation of PTEN transcription by p53
V Stambolic et al.
MOLECULAR CELL (2001)
T cell-specific loss of Pten leads to defects in central and peripheral tolerance
A Suzuki et al.
IMMUNITY (2001)
Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression
J Hutchinson et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways
LP Weng et al.
HUMAN MOLECULAR GENETICS (2001)
The conserved phosphoinositide 3-kinase pathway determines heart size in mice
T Shioi et al.
EMBO JOURNAL (2000)
Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice
EC Holland et al.
NATURE GENETICS (2000)
分享论文
